Phase II trial of temozolomide in patients with relapsed sensitive or refractory small cell lung cancer, with assessment of methylguanine-DNA methyltransferase as a potential biomarker (Q33399073)
Jump to navigation
Jump to search
scientific article
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Phase II trial of temozolomide in patients with relapsed sensitive or refractory small cell lung cancer, with assessment of methylguanine-DNA methyltransferase as a potential biomarker |
scientific article |
Statements
1 reference
Phase II trial of temozolomide in patients with relapsed sensitive or refractory small cell lung cancer, with assessment of methylguanine-DNA methyltransferase as a potential biomarker (English)
1 reference
Camelia S Sima
1 reference
M Catherine Pietanza
1 reference
Kyuichi Kadota
1 reference
Kety Huberman
1 reference
John J Fiore
1 reference
Dyana K Sumner
1 reference
William D Travis
1 reference
Adriana Heguy
1 reference
Michelle S Ginsberg
1 reference
Andrei I Holodny
1 reference
Timothy A Chan
1 reference
Naiyer A Rizvi
1 reference
Christopher G Azzoli
1 reference
Gregory J Riely
1 reference
Lee M Krug
1 reference
6 January 2012
1 reference
1 reference
18
1 reference
1138-1145
1 reference
Identifiers
1 reference
1 reference